Literature DB >> 6124631

Leukotriene B4 in synovial fluid.

E M Davidson, S A Rae, M J Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124631     DOI: 10.1111/j.2042-7158.1982.tb04745.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  10 in total

1.  Effect of auranofin on eicosanoids and protein kinase C in human neutrophils.

Authors:  T Herlin; K Fogh; N O Christiansen; K Kragballe
Journal:  Agents Actions       Date:  1989-08

2.  Leukotriene B4 metabolism in human leukocytes: fact or artefact?

Authors:  R M McMillan; S J Foster; P A Dieppe
Journal:  Agents Actions       Date:  1987-08

3.  Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids.

Authors:  N Ahmadzadeh; M Shingu; M Nobunaga; T Tawara
Journal:  Inflammation       Date:  1991-12       Impact factor: 4.092

Review 4.  The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.

Authors:  R A Lewis; K F Austen
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

5.  Leukotrienes in disease. Implications for drug development.

Authors:  G A Higgs; S Moncada
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

Review 6.  Leukotrienes, allergy and inflammation.

Authors:  F P Nijkamp; J M Sitsen
Journal:  Pharm Weekbl Sci       Date:  1982-12-17

Review 7.  The arachidonic acid cascade. The prostaglandins, thromboxanes and leukotrienes.

Authors:  E Granström
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

Review 8.  [Eicosanoids and phospholipases].

Authors:  M Goerig; A J Habenicht; G Schettler
Journal:  Klin Wochenschr       Date:  1985-04-01

9.  Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.

Authors:  E M Davidson; S A Rae; M J Smith
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

10.  Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4.

Authors:  R D Camp; A A Coutts; M W Greaves; A B Kay; M J Walport
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.